Keeler T Homas Management LLC Abb Vie Inc. Transaction History

Keeler T Homas Management LLC

$310 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $288,589 - $366,891	-2,097 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $77,340 - $95,957	-586 Reduced 21.84%	2,097 $340,000
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $8,916 - $11,282	-83 Reduced 3.0%	2,683 $363,000
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $281,120 - $309,479	-2,748 Reduced 49.84%	2,766 $299,000
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $2.23 Million - $3.02 Million	-27,748 Reduced 83.42%	5,514 $590,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $545,614 - $640,371	6,351 Added 23.6%	33,262 $2.91 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $804,208 - $1.08 Million	10,961 Added 68.72%	26,911 $2.64 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $824,116 - $1.25 Million	-12,777 Reduced 44.48%	15,950 $1.22 Million
Q4 2019 Jan 21, 2020	SELL	$72.13 - $90.25 $29,933 - $37,453	-415 Reduced 1.42%	28,727 $2.54 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $296,257 - $356,186	4,704 Added 19.25%	29,142 $2.21 Million
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $266,085 - $340,119	4,050 Added 19.86%	24,438 $1.78 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $563,122 - $662,767	7,300 Added 55.78%	20,388 $1.64 Million
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $224,441 - $276,796	2,883 Added 28.25%	13,088 $1.21 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $419,388 - $466,228	4,717 Added 85.95%	10,205 $965,000
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $251,384 - $297,444	2,800 Added 104.17%	5,488 $508,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $349,638 - $468,198	-3,800 Reduced 58.57%	2,688 $254,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $581,065 - $637,186	6,488	6,488 $627,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeler T Homas Management LLC with notifications on news.

Account